Your browser is no longer supported. Please, upgrade your browser.
QTRX Quanterix Corporation daily Stock Chart
QTRX [NASD]
Quanterix Corporation
Index- P/E- EPS (ttm)-1.61 Insider Own3.90% Shs Outstand28.31M Perf Week-5.07%
Market Cap1.37B Forward P/E- EPS next Y-1.27 Insider Trans-13.00% Shs Float20.45M Perf Month25.87%
Income-44.70M PEG- EPS next Q-0.42 Inst Own79.10% Short Float3.76% Perf Quarter37.82%
Sales59.70M P/S22.89 EPS this Y-13.40% Inst Trans1.03% Short Ratio2.97 Perf Half Y82.35%
Book/sh3.92 P/B10.89 EPS next Y24.90% ROA-26.40% Target Price39.25 Perf Year103.68%
Cash/sh- P/C- EPS next 5Y- ROE-36.20% 52W Range10.90 - 48.95 Perf YTD80.58%
Dividend- P/FCF- EPS past 5Y- ROI-30.40% 52W High-12.83% Beta-
Dividend %- Quick Ratio5.30 Sales past 5Y- Gross Margin43.40% 52W Low291.65% ATR2.23
Employees248 Current Ratio6.00 Sales Q/Q-3.00% Oper. Margin-76.70% RSI (14)63.38 Volatility4.29% 5.94%
OptionableNo Debt/Eq0.00 EPS Q/Q4.50% Profit Margin-74.90% Rel Volume0.43 Prev Close42.34
ShortableYes LT Debt/Eq0.07 EarningsAug 04 AMC Payout- Avg Volume259.18K Price42.67
Recom- SMA2012.64% SMA5019.64% SMA20054.10% Volume112,505 Change0.78%
Oct-07-20 04:27PM  
Oct-06-20 03:32PM  
Oct-05-20 04:01PM  
Sep-10-20 09:00AM  
Aug-25-20 12:28PM  
Aug-11-20 04:34PM  
09:00AM  
Aug-06-20 10:12PM  
04:11PM  
Aug-04-20 04:29PM  
Aug-03-20 09:08AM  
Jul-29-20 09:30AM  
Jul-27-20 07:00AM  
Jul-20-20 10:41AM  
Jul-05-20 10:02PM  
Jun-26-20 09:37AM  
Jun-11-20 04:10PM  
May-29-20 12:37PM  
May-13-20 09:45AM  
May-11-20 09:14AM  
08:26AM  
May-06-20 10:02AM  
May-05-20 04:05PM  
May-01-20 11:00AM  
Apr-28-20 02:45PM  
Apr-24-20 06:04PM  
Apr-14-20 10:05AM  
Apr-10-20 04:00PM  
Apr-09-20 01:15PM  
Mar-27-20 09:45AM  
Mar-11-20 08:13AM  
Mar-09-20 04:05PM  
Feb-21-20 04:32PM  
Feb-11-20 11:44AM  
Jan-31-20 10:04AM  
Jan-10-20 02:03PM  
Dec-19-19 04:23PM  
Dec-11-19 10:27AM  
Nov-06-19 04:01PM  
Nov-04-19 04:00PM  
Nov-01-19 09:41AM  
Oct-25-19 09:13AM  
Oct-22-19 04:30PM  
Oct-18-19 11:13AM  
Oct-03-19 09:00AM  
Oct-01-19 09:46AM  
Sep-26-19 07:00AM  
Sep-24-19 01:14PM  
Sep-16-19 06:21PM  
Sep-11-19 08:00AM  
Aug-13-19 04:21PM  
Aug-09-19 07:45AM  
Aug-07-19 04:23PM  
08:25AM  
Aug-06-19 08:30AM  
Jul-31-19 09:00AM  
Jul-30-19 10:30AM  
Jul-26-19 11:16AM  
Jul-11-19 01:30PM  
Jun-28-19 12:15PM  
Jun-27-19 10:43AM  
Jun-26-19 04:00PM  
Jun-06-19 07:03AM  
Jun-04-19 04:00PM  
May-29-19 04:00PM  
May-16-19 10:30AM  
May-11-19 01:27PM  
May-10-19 11:23AM  
May-09-19 04:00PM  
May-06-19 11:30AM  
May-02-19 04:00PM  
Apr-01-19 07:14AM  
Mar-28-19 04:00PM  
Mar-18-19 05:48PM  
Mar-08-19 01:15AM  
Mar-07-19 04:00PM  
Feb-26-19 04:00PM  
Feb-21-19 02:45PM  
Feb-19-19 06:04AM  
Jan-14-19 11:45AM  
Jan-10-19 12:00PM  
Jan-04-19 04:17PM  
Dec-20-18 10:11AM  
Dec-13-18 03:08PM  
Nov-26-18 01:00PM  
Nov-21-18 08:15AM  
Nov-13-18 04:00PM  
Nov-07-18 09:00AM  
Nov-01-18 04:00PM  
Oct-25-18 04:05PM  
Oct-22-18 04:30PM  
Oct-09-18 12:00AM  
Sep-26-18 09:00AM  
Sep-18-18 10:45AM  
Sep-12-18 05:15PM  
Sep-05-18 09:00AM  
Aug-08-18 04:00PM  
Aug-06-18 09:32AM  
Jul-30-18 09:00AM  
Jul-26-18 09:00AM  
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also develops SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include kits, such as beads, capture and detector reagents, enzyme reagents, and enzyme substrates to run tests; and consumables, such as proprietary Simoa disks, cuvettes, and disposable tips. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sell its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HRUSOVSKY E KEVINChairman, President & CEOOct 13Sale44.492,00088,9801,033,798Oct 15 05:36 PM
Madaus Martin DDirectorOct 07Option Exercise2.281,6003,64813,316Oct 08 05:43 PM
Madaus Martin DDirectorOct 07Sale37.171,60059,47211,716Oct 08 05:43 PM
Madaus Martin DDirectorOct 06Option Exercise2.281,6003,64813,316Oct 08 05:43 PM
Madaus Martin DDirectorOct 06Sale36.471,60058,35711,716Oct 08 05:43 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 05Sale33.902,00067,8001,035,798Oct 05 05:29 PM
Fry John JGeneral Counsel & SecretaryOct 01Sale34.121434,88031,227Oct 02 04:00 PM
HRUSOVSKY E KEVINChairman, President & CEOOct 01Sale34.123,286112,1261,037,798Oct 02 04:00 PM
Mattoon DawnSr. VP, Research ProductsOct 01Sale34.121595,42531,503Oct 02 04:00 PM
Chaubal AmolChief Financial OfficerOct 01Sale34.121163,95825,377Oct 02 04:00 PM
Roskey Mark T.SVP, Commercial & AcceleratorOct 01Sale34.12923,13921,279Oct 02 04:00 PM
Madaus Martin DDirectorSep 29Option Exercise1.961,6003,13812,654Sep 30 04:10 PM
Madaus Martin DDirectorSep 29Sale32.521,60052,02511,196Sep 30 04:10 PM
Madaus Martin DDirectorSep 28Option Exercise1.931,6003,08812,796Sep 30 04:10 PM
Madaus Martin DDirectorSep 28Sale33.091,60052,94411,196Sep 30 04:10 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 24Sale32.262,00064,5201,041,084Sep 29 04:53 PM
Madaus Martin DDirectorSep 17Option Exercise1.931,6003,08812,796Sep 17 05:49 PM
Duffy David C.SVP R&D and CTOSep 17Sale32.431,66754,06144,511Sep 17 05:47 PM
Madaus Martin DDirectorSep 17Sale32.431,60051,88811,196Sep 17 05:49 PM
Madaus Martin DDirectorSep 16Option Exercise1.931,6003,08812,796Sep 17 05:49 PM
Madaus Martin DDirectorSep 16Sale33.161,60053,05611,196Sep 17 05:49 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 15Sale33.153,500116,0371,043,084Sep 16 04:08 PM
Madaus Martin DDirectorSep 02Option Exercise1.931,6003,08812,796Sep 03 07:44 PM
Madaus Martin DDirectorSep 02Sale35.081,60056,12811,196Sep 03 07:44 PM
Madaus Martin DDirectorSep 01Option Exercise1.931,6003,08812,796Sep 03 07:44 PM
Madaus Martin DDirectorSep 01Sale35.371,60056,59211,196Sep 03 07:44 PM
HRUSOVSKY E KEVINChairman, President & CEOSep 01Sale34.913,390118,3491,046,584Sep 03 07:48 PM
Mattoon DawnSr. VP, Research ProductsSep 01Sale34.911655,76031,662Sep 03 07:50 PM
Fry John JGeneral Counsel & SecretarySep 01Sale34.911485,16731,370Sep 03 07:52 PM
Chaubal AmolChief Financial OfficerSep 01Sale34.911204,18925,493Sep 03 07:54 PM
Roskey Mark T.SVP, Commercial & AcceleratorSep 01Sale34.91953,31721,371Sep 03 07:56 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 25Sale35.283,500123,4681,049,974Aug 26 05:09 PM
Madaus Martin DDirectorAug 19Option Exercise1.931,6003,08812,796Aug 20 04:32 PM
Duffy David C.SVP R&D and CTOAug 19Sale34.921,68058,66646,178Aug 20 04:32 PM
Madaus Martin DDirectorAug 19Sale34.921,60055,87211,196Aug 20 04:32 PM
Madaus Martin DDirectorAug 18Option Exercise1.931,6003,08812,796Aug 20 04:32 PM
Madaus Martin DDirectorAug 18Sale34.521,60055,23211,196Aug 20 04:32 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 14Sale36.723,500128,5331,053,474Aug 14 05:40 PM
DEKKERS MARIJN EDirectorAug 07Sale32.4927,619897,3410Aug 11 04:52 PM
Madaus Martin DDirectorAug 05Option Exercise1.933,2006,17614,396Aug 05 05:49 PM
Madaus Martin DDirectorAug 05Sale32.893,200105,24811,196Aug 05 05:49 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 04Sale32.114,000128,4371,056,974Aug 05 05:14 PM
Mattoon DawnSr. VP, Research ProductsAug 03Sale32.261565,03231,827Aug 05 05:53 PM
Roskey Mark T.SVP, Commercial & AcceleratorAug 03Sale32.25902,90321,466Aug 05 05:51 PM
Fry John JGeneral Counsel & SecretaryAug 03Sale32.251414,54831,518Aug 05 05:10 PM
HRUSOVSKY E KEVINChairman, President & CEOAug 03Sale32.263,230104,1881,060,974Aug 05 05:14 PM
Chaubal AmolChief Financial OfficerAug 03Sale32.261143,67725,613Aug 05 05:21 PM
Madaus Martin DDirectorJul 21Option Exercise1.931,6003,08812,796Jul 22 07:13 PM
HRUSOVSKY E KEVINChairman, President & CEOJul 21Sale31.872,63684,0161,064,204Jul 23 08:38 PM
Madaus Martin DDirectorJul 21Sale31.451,60050,32011,196Jul 22 07:13 PM
Madaus Martin DDirectorJul 20Option Exercise1.931,6003,08812,796Jul 22 07:13 PM
Madaus Martin DDirectorJul 20Sale31.051,60049,68011,196Jul 22 07:13 PM
HRUSOVSKY E KEVINChairman, President & CEOJul 16Sale27.944,500125,7301,066,840Jul 17 06:05 PM
Duffy David C.SVP R&D and CTOJul 13Sale27.391,66745,65947,858Jul 14 05:49 PM
Madaus Martin DDirectorJul 09Option Exercise1.931,6003,08812,796Jul 10 04:10 PM
Madaus Martin DDirectorJul 09Sale26.851,60042,96011,196Jul 10 04:10 PM
Madaus Martin DDirectorJul 08Option Exercise1.931,6003,08812,796Jul 10 04:10 PM
Madaus Martin DDirectorJul 08Sale27.001,60043,20011,196Jul 10 04:10 PM
Fry John JGeneral Counsel & SecretaryJul 01Sale26.871443,87031,659Jul 06 04:12 PM
Chaubal AmolChief Financial OfficerJul 01Sale26.871173,14425,727Jul 06 04:12 PM
HRUSOVSKY E KEVINChairman, President & CEOJul 01Sale26.873,29788,6011,071,340Jul 06 04:13 PM
Roskey Mark T.SVP, Commercial & AcceleratorJul 01Sale26.88922,47321,556Jul 06 04:11 PM
Mattoon DawnSr. VP, Research ProductsJul 01Sale26.871594,27331,983Jul 06 04:12 PM
Madaus Martin DDirectorJun 25Option Exercise1.931,6003,08812,145Jun 26 04:01 PM
Madaus Martin DDirectorJun 25Sale26.081,60041,72810,545Jun 26 04:01 PM
Madaus Martin DDirectorJun 24Option Exercise1.931,6003,08812,145Jun 26 04:01 PM
Madaus Martin DDirectorJun 24Sale26.391,60042,22410,545Jun 26 04:01 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 23Sale27.075,000135,3451,074,637Jun 25 04:01 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 18Sale26.885,500147,8261,079,637Jun 22 04:04 PM
Duffy David C.SVP R&D and CTOJun 16Sale26.351,66743,92549,525Jun 18 04:58 PM
Roskey Mark T.SVP, Commercial & AcceleratorJun 15Option Exercise2.965,00014,80026,648Jun 15 07:04 PM
Roskey Mark T.SVP, Commercial & AcceleratorJun 15Sale24.805,000124,02521,648Jun 15 07:04 PM
Fry John JGeneral Counsel & SecretaryJun 11Sale24.771,84245,61831,803Jun 12 04:36 PM
Madaus Martin DDirectorJun 09Option Exercise1.931,6003,08812,145Jun 10 04:09 PM
Madaus Martin DDirectorJun 09Sale25.371,60040,59210,545Jun 10 04:09 PM
Madaus Martin DDirectorJun 08Option Exercise1.931,6003,08812,145Jun 10 04:09 PM
Madaus Martin DDirectorJun 08Sale25.901,60041,44010,545Jun 10 04:09 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 03Sale27.495,000137,4721,085,137Jun 03 06:59 PM
Chaubal AmolChief Financial OfficerJun 01Sale27.321183,22425,844Jun 03 07:01 PM
HRUSOVSKY E KEVINChairman, President & CEOJun 01Sale27.323,33190,9981,090,137Jun 03 06:59 PM
Mattoon DawnSr. VP, Research ProductsJun 01Sale27.321624,42632,142Jun 03 06:50 PM
Roskey Mark T.SVP, Commercial & AcceleratorJun 01Sale27.32932,54121,648Jun 03 06:46 PM
Madaus Martin DDirectorMay 28Option Exercise1.931,6003,08812,145May 29 05:13 PM
Madaus Martin DDirectorMay 28Sale26.511,60042,41610,545May 29 05:13 PM
Madaus Martin DDirectorMay 27Option Exercise1.931,6003,08812,145May 29 05:13 PM
Madaus Martin DDirectorMay 27Sale26.021,60041,63210,545May 29 05:13 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 26Sale25.645,000128,2241,093,468May 28 04:35 PM
Roskey Mark T.SVP, Commercial & AcceleratorMay 18Option Exercise2.965,00014,80026,741May 20 05:55 PM
Roskey Mark T.SVP, Commercial & AcceleratorMay 18Sale25.605,000128,01221,741May 20 05:55 PM
Madaus Martin DDirectorMay 13Option Exercise1.931,6003,08812,145May 14 05:45 PM
Madaus Martin DDirectorMay 13Sale26.601,60042,56010,545May 14 05:45 PM
Madaus Martin DDirectorMay 12Option Exercise1.931,6003,08812,145May 14 05:45 PM
Madaus Martin DDirectorMay 12Sale27.861,60044,57610,545May 14 05:45 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 11Sale27.475,000137,3721,098,468May 12 07:16 PM
Duffy David C.SVP R&D and CTOMay 08Sale26.521,66744,20951,192May 12 06:21 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 06Sale27.095,000135,4571,103,468May 08 04:35 PM
HRUSOVSKY E KEVINChairman, President & CEOMay 01Sale25.443,39986,4781,108,468May 04 05:22 PM
Mattoon DawnSr. VP, Research ProductsMay 01Sale25.441654,19832,304May 04 05:20 PM
Roskey Mark T.SVP, Commercial & AcceleratorMay 01Sale25.44952,41721,741May 04 05:18 PM
Chaubal AmolChief Financial OfficerMay 01Sale25.441203,05325,962Jun 03 07:01 PM